Trial
NCT03189186
Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, Irvine
Collaborators
—
Condition
Renal Cell Carcinoma
Intervention
Pembrolizumab Injection [Keytruda]
Why stopped
This study was closed due to extremely low accrual, as well as a change in care when using the study drug.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-05